227 Patient pre-selection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa:ESDR 2017 Annual Meeting47th Annual ESDR Meeting

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image